TELA Bio to Announce First Quarter 2025 Financial Results
TELA Bio (NASDAQ: TELA), a commercial-stage medical technology company specializing in soft-tissue reconstruction solutions, has scheduled its first quarter 2025 financial results announcement for Thursday, May 8, 2025. The company will host a conference call and webcast at 4:30 p.m. ET on the same day, featuring management discussions on financial performance and corporate updates.
Interested investors must register for the conference call at least 15 minutes before it begins. The event will be accessible through a live webcast and replay via the Events & Presentations section of TELA's investor website.
TELA Bio (NASDAQ: TELA), un'azienda tecnologica medica in fase commerciale specializzata in soluzioni per la ricostruzione dei tessuti molli, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per giovedì 8 maggio 2025. La società terrà una conference call e una diretta web alle 16:30 ET dello stesso giorno, durante le quali il management discuterà delle performance finanziarie e degli aggiornamenti aziendali.
Gli investitori interessati devono registrarsi alla conference call almeno 15 minuti prima dell'inizio. L'evento sarà accessibile tramite una diretta web e una replica nella sezione Eventi e Presentazioni del sito dedicato agli investitori di TELA.
TELA Bio (NASDAQ: TELA), una empresa de tecnología médica en fase comercial especializada en soluciones para la reconstrucción de tejidos blandos, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el jueves 8 de mayo de 2025. La compañía realizará una conferencia telefónica y una transmisión en vivo a las 4:30 p.m. ET del mismo día, donde la dirección discutirá el desempeño financiero y las actualizaciones corporativas.
Los inversores interesados deben registrarse para la conferencia telefónica al menos 15 minutos antes de que comience. El evento estará disponible en una transmisión en vivo y en repetición a través de la sección de Eventos y Presentaciones en el sitio web para inversores de TELA.
TELA Bio (NASDAQ: TELA)는 연조직 재건 솔루션을 전문으로 하는 상업 단계의 의료 기술 회사로, 2025년 1분기 재무 결과 발표를 2025년 5월 8일 목요일로 예정했습니다. 회사는 같은 날 오후 4시 30분(동부 시간)에 경영진이 재무 성과와 회사 업데이트에 대해 논의하는 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
참여를 원하는 투자자는 컨퍼런스 콜 시작 최소 15분 전에 등록해야 합니다. 본 행사는 TELA 투자자 웹사이트의 이벤트 및 프레젠테이션 섹션을 통해 라이브 웹캐스트 및 재방송으로 시청할 수 있습니다.
TELA Bio (NASDAQ : TELA), une société de technologie médicale en phase commerciale spécialisée dans les solutions de reconstruction des tissus mous, a prévu l'annonce de ses résultats financiers du premier trimestre 2025 pour le jeudi 8 mai 2025. La société organisera une conférence téléphonique et une diffusion en direct à 16h30 ET le même jour, au cours desquelles la direction discutera des performances financières et des mises à jour de l'entreprise.
Les investisseurs intéressés doivent s'inscrire à la conférence téléphonique au moins 15 minutes avant le début. L'événement sera accessible via une diffusion en direct et un replay dans la section Événements et Présentations du site web des investisseurs de TELA.
TELA Bio (NASDAQ: TELA), ein medizinisches Technologieunternehmen in der kommerziellen Phase, das sich auf Lösungen zur Weichgeweberekonstruktion spezialisiert hat, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für Donnerstag, den 8. Mai 2025 geplant. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und einen Webcast veranstalten, bei denen das Management die finanzielle Leistung und Unternehmensupdates besprechen wird.
Interessierte Investoren müssen sich mindestens 15 Minuten vor Beginn der Telefonkonferenz registrieren. Die Veranstaltung wird über einen Live-Webcast und eine Wiederholung im Bereich „Events & Präsentationen“ auf der Investorenseite von TELA zugänglich sein.
- None.
- None.
MALVERN, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report first quarter 2025 financial results on Thursday, May 8, 2025. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
First Quarter Earnings Conference Call and Webcast Details
Investors interested in listening to the conference call should register online. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed via the Events & Presentations page of the investor section of TELA's website.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Caution Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements and reflect the current beliefs of TELA Bio's management. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors that could cause actual results and events to differ materially and adversely from those indicated by such forward-looking statements. These risks and uncertainties are described more fully in the "Risk Factors" section and elsewhere in our filings with the Securities and Exchange Commission and available at www.sec.gov, including in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements that we make in this announcement speak only as of the date of this press release, and TELA Bio assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise after the date of this press release, except as required under applicable law.
Investor Contact
Louisa Smith
ir@telabio.com
FAQ
When will TELA Bio release its Q1 2025 earnings report?
How can investors participate in TELA Bio's Q1 2025 earnings call?
What is TELA Bio's main business focus?
What stock exchange is TELA Bio listed on?
